个人简历
毕业于北京协和医学院，获临床医学博士学位。主攻乳腺癌及头颈部肿瘤的内科治疗和转化研究，主持国家自然科学青年基金、中山大学青年教师培育基金，参与中山大学5010、中山大学肿瘤防治中心308项目等多项临床研究。作为第一作者或通讯作者在国际知名杂志发表SCI论文十余篇，其中单篇最高影响因子10.2（Clin Cancer Res），2篇被美国NCCN指南采纳。
研究领域
乳腺癌、头颈部肿瘤的内科治疗
近期论文
(1)Bi XW, Xia Y, Zhang WW, Sun P, Liu PP, Wang Y, Huang JJ, Jiang WQ, Li ZM. Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma. Ann Hematol. 2015 Sep;94(9):1525-33. (IF = 3.083，本文被2016-2018年NCCN指南采纳为2A类证据) (2)Bi XW, Jiang WQ, Zhang WW, Huang JJ, Xia Y, Wang Y, Sun P, Li ZM. Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy. Ann Hematol. 2015 Jul;94(7):1175-84. (IF = 3.083，本文被2018年NCCN指南引用) (3)Bi XW, Wang H, Zhang WW, Wang JH, Liu WJ, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ, Wang L. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma. J Hematol Oncol. 2016 Oct 13;9(1):109. (IF = 6.328) (4)Bi XW, Li YX, Fang H, Jin J, Wang WH, Wang SL, Liu YP, Song YW, Ren H, Dai JR. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1086-93. (IF = 5.133) (5)Bi XW, Zhang WW, Li ZM, Huang JJ, Xia Y, Sun P, Wang Y, Jiang WQ. The extent of local tumor invasion predicts prognosis in stage IE nasal natural killer/T-cell lymphoma: a novel T staging system for risk stratification. Ann Hematol. 2015;94(9):1515-24. (IF = 3.083) (6)Bi XW, Wang L, Zhang WW, Sun P, Yan SM, Liu PP, Li ZM, Jiang WQ. High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma. PLoS One. 2016 Mar 31;11(3):e0152842. (IF = 2.806) (7)Bi XW, Wang L, Zhang WW, Yan SM, Sun P, Xia Y, Li ZM, Jiang WQ. The pretreatment albumin to globulin ratio predicts survival in patients with natural killer/T-cell lymphoma. Peer J. 2016 Mar 3;4:e1742. (IF = 2.177) (8)Nie M, Bi XW (共一), Zhang WW, Sun P, Xia Y, Liu PP, Huang HQ, Jiang WQ, Li ZM. Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma. Sci Rep. 2016 Apr 4;6. (IF = 4.257) (9)Wang JH, Bi XW (共一), Li PF, Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ, Wang L. Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type. J Cancer. 2017 Feb 25;8(5):793-800. (IF = 2.916) (10)Wang L, Bi XW (共一), Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ. Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy. Onco Targets Ther. 2016 Sep 26;9:5875. (IF = 2.355) (11)Wang L, Wang JH, Bi XW (共一), Chen XQ, Lv Y, Xia ZJ. Interim PET-CT may predict PFS and OS in T-ALL/LBL adult patients. Oncotargets. 2017;8:99104-99111. (IF = 5.168)
